SI3869199T1 - Postopek in reagenti za diagnozo SARS-COV-2 - Google Patents
Postopek in reagenti za diagnozo SARS-COV-2Info
- Publication number
- SI3869199T1 SI3869199T1 SI202030035T SI202030035T SI3869199T1 SI 3869199 T1 SI3869199 T1 SI 3869199T1 SI 202030035 T SI202030035 T SI 202030035T SI 202030035 T SI202030035 T SI 202030035T SI 3869199 T1 SI3869199 T1 SI 3869199T1
- Authority
- SI
- Slovenia
- Prior art keywords
- cov
- sars
- reagents
- diagnosis
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/165—Coronaviridae, e.g. avian infectious bronchitis virus
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20158626.0A EP3715847A1 (en) | 2020-02-20 | 2020-02-20 | A method and reagents for the diagnosis of sars-cov-2 |
| EP20215445.6A EP3869199B1 (en) | 2020-02-20 | 2020-02-20 | A method and reagents for the diagnosis of sars-cov-2 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI3869199T1 true SI3869199T1 (sl) | 2022-05-31 |
Family
ID=69726444
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI202030035T SI3869199T1 (sl) | 2020-02-20 | 2020-02-20 | Postopek in reagenti za diagnozo SARS-COV-2 |
Country Status (10)
| Country | Link |
|---|---|
| EP (3) | EP3869200A1 (sl) |
| DE (1) | DE20158626T1 (sl) |
| DK (1) | DK3869199T3 (sl) |
| ES (2) | ES2788459T1 (sl) |
| HR (1) | HRP20220373T1 (sl) |
| HU (1) | HUE058338T2 (sl) |
| LT (1) | LT3869199T (sl) |
| PL (1) | PL3869199T3 (sl) |
| PT (1) | PT3869199T (sl) |
| SI (1) | SI3869199T1 (sl) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021186029A1 (en) * | 2020-03-20 | 2021-09-23 | Deutsches Krebsforschungszentrum | Sars spike peptides and uses thereof |
| GB202006815D0 (en) * | 2020-05-07 | 2020-06-24 | Senseutics Ltd | Method |
| WO2021222988A1 (en) * | 2020-05-07 | 2021-11-11 | Griffith University | Cell entry-modulating agents and uses therefor |
| DE20175031T1 (de) | 2020-05-15 | 2021-09-09 | Euroimmun Medizinische Labordiagnostika Ag | Verfahren zur Bestimmung der Wirksamkeit eines SARS-CoV-2 Impfstoffs |
| CN111551715B (zh) * | 2020-05-18 | 2022-04-22 | 天津博奥赛斯生物科技股份有限公司 | 一种新型冠状病毒IgM抗体的酶联免疫法检测试剂盒 |
| EP3913369A1 (en) * | 2020-05-20 | 2021-11-24 | Diesse Diagnostica Senese S.p.a. | Method for inactivating sars-cov-2 and uses thereof |
| CN111848753B (zh) * | 2020-07-20 | 2022-03-15 | 中国科学院过程工程研究所 | 新型冠状病毒抗原表位及其应用 |
| DE102020125915B3 (de) | 2020-10-02 | 2022-03-03 | Institut für Molekulare Diagnostik und Bioanalytik | Immundiagnostische mittel und verfahren für den nachweis und die differenzierung von coronavirus-infektionen |
| CN112251414A (zh) * | 2020-10-12 | 2021-01-22 | 中国科学院苏州纳米技术与纳米仿生研究所 | 一种杂交瘤细胞株、其制备方法和应用 |
| KR20220054080A (ko) * | 2020-10-23 | 2022-05-02 | 주식회사 와이바이오로직스 | SARS-CoV-2 스파이크 단백질에 특이적으로 결합하는 항체 및 이의 용도 |
| TW202237626A (zh) * | 2020-11-12 | 2022-10-01 | 美商帝斯肯醫療公司 | Ｓａｒｓ－ｃｏｖ－２免疫顯性肽構築體及其用途 |
| WO2022109751A1 (en) * | 2020-11-27 | 2022-06-02 | The University Of Western Ontario | Point-of-care testing for sars-cov antibodies |
| EP4263576A2 (en) * | 2020-12-18 | 2023-10-25 | The Scripps Research Institute | Immunogenic compositions |
| CN112611870B (zh) * | 2020-12-21 | 2022-09-16 | 杭州宝临生物科技有限公司 | 预测新型冠状病毒中和抗体效价的方法及其试剂盒 |
| CN112379090B (zh) * | 2021-01-07 | 2021-04-16 | 北京百普赛斯生物科技股份有限公司 | 新型冠状病毒抗体检测试剂盒及其制备方法与应用 |
| CN112946261A (zh) * | 2021-01-14 | 2021-06-11 | 广州中医药大学顺德医院(佛山市顺德区中医院) | 一种基于三聚体s蛋白rbd-ace2结合竞争的新冠病毒中和抗体检测试剂盒 |
| CN112415189B (zh) * | 2021-01-22 | 2021-03-30 | 北京百普赛斯生物科技股份有限公司 | 偶联新型冠状病毒s2蛋白的磁珠及其制备方法与应用 |
| WO2022159834A1 (en) * | 2021-01-22 | 2022-07-28 | La Jolla Institute For Immunology | Chimeric anti-coronavirus spike protein antibodies |
| CN113278067B (zh) * | 2021-02-09 | 2022-06-28 | 武汉中生毓晋生物医药有限责任公司 | 一种新型冠状病毒猪源性免疫球蛋白的制备方法 |
| CN113238046A (zh) * | 2021-04-30 | 2021-08-10 | 深圳迈瑞生物医疗电子股份有限公司 | 检测冠状病毒抗体的试剂盒、冠状病毒抗体的检测方法 |
| CN114371159B (zh) * | 2021-05-19 | 2023-11-07 | 南京医科大学第二附属医院 | 一种rna生物芯片及其制备方法与应用 |
| CN114231497B (zh) * | 2022-02-24 | 2022-05-20 | 广州伯尼兹生物科技有限公司 | 一株表达SARS-CoV-2 S1蛋白单克隆抗体杂交瘤细胞系及中和活性抗体 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1648927A1 (en) | 2003-07-21 | 2006-04-26 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Soluble fragments of the sars-cov spike glycoprotein |
| CN1609617B (zh) * | 2003-09-29 | 2012-02-15 | 香港中文大学 | 诊断与预防严重急性呼吸道综合症（sars）的组合物和方法 |
| US20050282154A1 (en) | 2003-10-06 | 2005-12-22 | The Brigham And Women's Hospital, Inc. | Angiotensin-converting enzyme-2 as a receptor for the SARS coronavirus |
| TWI303249B (en) | 2004-01-09 | 2008-11-21 | Nat Health Research Institutes | Receptor binding polypeptides |
| CA2568838A1 (en) * | 2004-06-04 | 2005-12-15 | Institut Pasteur | Nucleic acids, polypeptides, methods of expression, and immunogenic compositions associated with sars corona virus spike protein |
| US20060188519A1 (en) * | 2004-06-14 | 2006-08-24 | To Cheung | Peptides, antibodies, and methods for the diagnosis of SARS |
| US20080269115A1 (en) * | 2004-06-17 | 2008-10-30 | Beadenkopf Robert J | Immunogenic Sars Domain |
| KR20150064104A (ko) | 2012-09-23 | 2015-06-10 | 에라스무스 유니버시티 메디컬 센터 로테르담 | 사람 베타 코로나바이러스의 계통 c 및 이의 바이러스 수용체로서 n-말단 디펩티딜 펩티다아제의 확인 |
-
2020
- 2020-02-20 ES ES20158626T patent/ES2788459T1/es active Pending
- 2020-02-20 HR HRP20220373TT patent/HRP20220373T1/hr unknown
- 2020-02-20 EP EP20215513.1A patent/EP3869200A1/en not_active Withdrawn
- 2020-02-20 EP EP20215445.6A patent/EP3869199B1/en active Active
- 2020-02-20 HU HUE20215445A patent/HUE058338T2/hu unknown
- 2020-02-20 DK DK20215445.6T patent/DK3869199T3/da active
- 2020-02-20 PL PL20215445T patent/PL3869199T3/pl unknown
- 2020-02-20 ES ES20215445T patent/ES2910184T3/es active Active
- 2020-02-20 LT LTEP20215445.6T patent/LT3869199T/lt unknown
- 2020-02-20 EP EP20158626.0A patent/EP3715847A1/en active Pending
- 2020-02-20 SI SI202030035T patent/SI3869199T1/sl unknown
- 2020-02-20 DE DE20158626.0T patent/DE20158626T1/de active Pending
- 2020-02-20 PT PT202154456T patent/PT3869199T/pt unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE20158626T1 (de) | 2020-12-10 |
| HUE058338T2 (hu) | 2022-07-28 |
| PL3869199T3 (pl) | 2022-05-30 |
| DK3869199T3 (da) | 2022-03-07 |
| ES2910184T3 (es) | 2022-05-11 |
| EP3869200A1 (en) | 2021-08-25 |
| EP3715847A1 (en) | 2020-09-30 |
| PT3869199T (pt) | 2022-03-02 |
| EP3869199A1 (en) | 2021-08-25 |
| LT3869199T (lt) | 2022-07-11 |
| HRP20220373T1 (hr) | 2022-05-13 |
| EP3869199B1 (en) | 2022-02-09 |
| ES2788459T1 (es) | 2020-10-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUE058338T2 (hu) | Eljárás és reagensek SARS-COV-2 diagnózisára | |
| EP3762929A4 (en) | SYSTEM AND PROCEDURE FOR REVIEWING AUTOMATED CLINICAL DOCUMENTATION | |
| EP3761861A4 (en) | AUTOMATED CLINICAL DOCUMENTATION SYSTEM AND PROCESS | |
| GB201802123D0 (en) | A method of processomg a biological sample | |
| IL296011A (en) | A method for measuring the brow value of a sample | |
| PL3688543T3 (pl) | Sposób nawigacji robota oraz robot do wykonywania sposobu | |
| GB202207821D0 (en) | Methods and systems for automated clinical workflows | |
| GB202105867D0 (en) | Method of developing and using a tool and the resulting tool, for automating complex processes | |
| EP3760070C0 (en) | GLOVE AND METHOD FOR PRODUCING THEREOF | |
| EP3847457A4 (en) | BODY FLUID TESTING PROCEDURE | |
| GB201914089D0 (en) | Apparatus and method for determining a biological characteristic | |
| EP3762928A4 (en) | AUTOMATED CLINICAL DOCUMENTATION SYSTEM AND METHOD | |
| PL4146765T3 (pl) | Sposób i reagenty do wzmacniania sygnału chemiluminescencyjnego | |
| EP4147227A4 (en) | SYSTEM AND METHOD FOR AUTOMATED MULTI-MICROPHONE CLINICAL DOCUMENTATION | |
| EP4061218A4 (en) | METHOD AND SYSTEM FOR EVALUATING BIOLOGICAL MOVEMENT | |
| IL281333A (en) | A method to reduce the risk in a clinical trial | |
| GB202000634D0 (en) | Diagnostic method | |
| KR102300228B9 (ko) | 진단보조정보를 제공하는 방법 및 이를 수행하는 장치 | |
| KR102300234B9 (ko) | 진단보조정보를 제공하는 방법 및 이를 수행하는 장치 | |
| SG10201900431QA (en) | A sterile reagent preparation device and the method of using the same | |
| PL3839565T3 (pl) | System i sposób kwantytatywnego wykrywania ruchu | |
| EP3623999C0 (en) | SYSTEM AND DEVICE FOR DETECTING AND ANALYZING A PERSON'S GAIT | |
| GB202012837D0 (en) | Diagnostic system and a method of diagnosing faults | |
| GB2609987B (en) | Diagnostic method | |
| GB202102823D0 (en) | Diagnostic method |